Pathways of complement activation in chronic discoid lupus: serologic and immunofluorescence studies

Area of Science:

• Immunology
• Dermatology
• Complement System

Background:

• Chronic discoid lupus erythematosus (CDLE) is an autoimmune condition affecting the skin.
• The roles of complement pathways in CDLE pathogenesis are not fully understood.
• Complement system activation is implicated in various autoimmune diseases.

Purpose of the Study:

• To investigate the involvement of the classic and alternative complement pathways in CDLE.
• To compare complement protein levels and deposition in CDLE patients with systemic lupus erythematosus (SLE) patients.

Main Methods:

• Serum levels of properdin, C3, and C4 were measured.
• Deposition of these proteins in the dermal-epidermal junction (DEJ) was assessed in skin biopsies.
• CDLE patients were compared to clinically active and inactive SLE patients and normal controls.

Main Results:

• Properdin deposition was found in 71% of CDLE skin lesions, often with immunoglobulin, C3, and C4.
• CDLE patients showed significantly increased serum properdin levels compared to normal controls and active SLE patients.
• Complement profiles (C3, C4, DNA-binding, ANA) in CDLE were similar to normals but distinct from active SLE.

Conclusions:

• The alternative complement pathway, indicated by properdin, appears to be significantly involved in CDLE skin lesions.
• Complement activation patterns in CDLE are distinct from active SLE and resemble inactive SLE.
• Properdin may serve as a biomarker or therapeutic target in CDLE.